Common side effects by peptide type Growth hormone peptides: Water retention (temporary) Lethargy initially (adapts within weeks) Carpal tunnel symptoms (rare, high doses) Insulin resistance (monitor with long-term use) IGF-1 LR3: Hypoglycemia (keep fast carbs on hand) Jaw/facial bone growth (with chronic use) Organ enlargement (long-term misuse) Healing peptides: Minimal side effects Occasionally: fatigue, headache (rare) Monitoring and bloodwork Baseline testing before starting: IGF-1 levels Thyroid panel (T3, T4, TSH) Fasting glucose and insulin Lipid panel Liver and kidney function Follow-up testing: Every 3-6 months during protocol Monitor IGF-1 (ensure not excessively elevated) Check glucose metabolism Liver/kidney function Contraindications Avoid peptides if: Active cancer (GH/IGF-1 can promote tumor growth) Diabetic without physician oversight Significant organ disease Use caution if: Family history of cancer Pre-diabetic Taking medications that affect blood sugar See our peptide safety and risks guide for comprehensive safety information
Recommended maintenance dose for weight loss: 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly
Innovations like single-use pre-filled syringes reduce contamination risks and enhance user safetycritical for medical-grade applications
Ive lost 15lbs within 3 weeks and ready to lose more
Questions to bring to your next appointment Are my B12 levels truly low
10 As of early 2023, available evidence generally lends support to a preferred approach to menopausal hormone therapy beginning within 10 years of menopause and comprising transdermal estradiol along with oral micronized progesterone for the management of vasomotor symptoms
